Skip to main content

Published works by Kathleen Stratton

LEX-AR-C8R984KA · complete body of work · page 1 of 1 · 21 works

Published works

CMS Proposes to Amend Overpayment Rule-Questions Remain Regarding How the Rule Will be Implemented Should CMS Adopt the False Claims Act’s “Reckless Disregard or Deliberate Ignorance” Standard
Healthcare Law Blog · July 22, 2024
LEX-WK-71WZ8C9N
CMS Proposes to Amend Overpayment Rule, Remove Potential Overpayment and False Claims Act Liability for Mere Negligence
Government Contracts & Investigations Blog · January 17, 2023
LEX-WK-GH0RQVPE
CMS Proposes to Amend Overpayment Rule, Remove Potential Overpayment and False Claims Act Liability for Mere Negligence
Healthcare Law Blog · December 27, 2022
LEX-WK-CM7S72GP
Supreme Court To Review DOJ’s Authority to Dismiss Qui Tam FCA Suits Over Objections From Relators
Healthcare Law Blog · June 30, 2022
LEX-WK-ZBT8PQGD
Supreme Court To Review DOJ’s Authority to Dismiss Qui Tam FCA Suits Over Objections From Relators
Government Contracts & Investigations Blog · June 29, 2022
LEX-WK-PAQPM5PS
OIG Issues Favorable Advisory Opinion for Physician-Owned Medical Device Company
Healthcare Law Blog · June 27, 2022
LEX-WK-B1C1T8QX
CMS Loosens Restrictions on Co-Located Healthcare Providers; Enforcement Interpretation Still to Be Determined
Healthcare Law Blog · December 3, 2021
LEX-WK-GEFZ2723
Executive Order on Promoting Competition in the American Economy: The Biden Administration Considers Drug Pricing Strategies While Keeping the “Most Favored Nations” Drug Reimbursement Program on the Sidelines
Healthcare Law Blog · August 20, 2021
LEX-WK-B1GWD5P6
Medicare Part B Most Favored Nation Drug Pricing Model: New Rules, New Lawsuits, New Tweets
Healthcare Law Blog · December 21, 2020
LEX-WK-ND5B9ZT7
CMS Finalizes Medicare Advantage Price Transparency Requirements, Despite Industry Criticism
Healthcare Law Blog · September 11, 2020
LEX-WK-1HWM4B54
CMS Issues Temporary Waivers in Broad Coronavirus Response
Healthcare Law Blog · April 2, 2020
LEX-WK-FGHJ7A99
Key Health Care Provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”)
Healthcare Law Blog · March 30, 2020
LEX-WK-HRPJN8FF
An Update: Despite Resistance, Surprise Billing Restrictions See Continued Legislative Activity
Healthcare Law Blog · March 2, 2020
LEX-WK-RAA6ZV1H
Surprise Billing Initiatives Face Not-So-Surprising Resistance
Healthcare Law Blog · December 13, 2019
LEX-WK-TMZQDEJM
Critical Analysis of CMS’ Proposed Stark Law Changes
Healthcare Law Blog · October 29, 2019
LEX-WK-1ZY4BCX9
CMS and OIG Propose Regulatory Changes Impacting the Scope of the Stark Law and the Federal Health Care Program Anti-Kickback Statute
Healthcare Law Blog · October 10, 2019
LEX-WK-PX383N7A
Long-Term Care Providers and Corporate Compliance Programs: The Impending November 28, 2019 Deadline is Fast Approaching
Healthcare Law Blog · September 6, 2019
LEX-WK-3J85N0WQ
CBO Report Shows Senate’s Bipartisan Bill on Surprise Billing, Drug Prices, Transparency, and More Would Result in Deficit Decrease
Healthcare Law Blog · July 29, 2019
LEX-WK-M7MYM1MW
CMS Proposes New Home Health Agency Rule Including Potential Changes to Reimbursement, Coverage, Quality, and More: CMS Accepting Comments until September 9, 2019
Healthcare Law Blog · July 16, 2019
LEX-WK-BTVKGBQ5
OIG Report on Topical Compounded Drug Prescribing, Marketing and Billing Practices Signals Heightened Administrative and Enforcement Scrutiny
Organizational Integrity Group Blog · November 2, 2018
LEX-WK-6GJ2CW7H
Blog Series Part 4: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021
Healthcare Law Blog · November 1, 2018
LEX-WK-EHYP1266